Cargando…

Quantitative evaluation of hepatic steatosis using novel ultrasound technology normalized local variance (NLV) and its standard deviation with different ROIs in patients with metabolic-associated fatty liver disease: a pilot study

PURPOSE: The purpose of this study was to evaluate the diagnostic performance of novel ultrasound technology normalized local variance (NLV) and the standard deviation of NLV (NLV-SD) using different ROIs for hepatic steatosis in patients with metabolic-associated fatty liver disease (MAFLD) and to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yanan, Zhang, Chao, Xu, Shaoyan, Zhang, Hui, Wei, Shumei, Huang, Pengfei, Zhang, Lufei, Wong, Yik Ning, Xu, Wen, Huang, Pintong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807465/
https://www.ncbi.nlm.nih.gov/pubmed/34958409
http://dx.doi.org/10.1007/s00261-021-03394-0
_version_ 1784643673064996864
author Zhao, Yanan
Zhang, Chao
Xu, Shaoyan
Zhang, Hui
Wei, Shumei
Huang, Pengfei
Zhang, Lufei
Wong, Yik Ning
Xu, Wen
Huang, Pintong
author_facet Zhao, Yanan
Zhang, Chao
Xu, Shaoyan
Zhang, Hui
Wei, Shumei
Huang, Pengfei
Zhang, Lufei
Wong, Yik Ning
Xu, Wen
Huang, Pintong
author_sort Zhao, Yanan
collection PubMed
description PURPOSE: The purpose of this study was to evaluate the diagnostic performance of novel ultrasound technology normalized local variance (NLV) and the standard deviation of NLV (NLV-SD) using different ROIs for hepatic steatosis in patients with metabolic-associated fatty liver disease (MAFLD) and to identify the factors that influence the NLV value and NLV-SD value, using pathology results as the gold standard. METHODS: We prospectively enrolled 34 consecutive patients with suspected MAFLD who underwent percutaneous liver biopsy for evaluation of hepatic steatosis from June 2020 to December 2020. All patients underwent ultrasound and NLV examinations. NLV values and NLV-SD values were measured using different ROIs just before the liver biopsy procedure. RESULTS: The distribution of hepatic steatosis grade on histopathology was 4/19/6/5 for none (< 5%)/ mild (5–33%)/ moderate (> 33–66%)/ and severe steatosis (> 66%), respectively. The NLV value with 50-mm-diameter ROI and NLV-SD value with 50-mm-diameter ROI showed a significant negative correlation with hepatic steatosis (spearman correlation coefficient: − 0.449, p = 0.008; − 0.471, p = 0.005). The AUROC of NLV (50 mm) for the detection of mild, moderate, and severe hepatic steatosis was 0.875, 0.735, and 0.583, respectively. The AUROC of NLV-SD (50 mm) for the detection of mild, moderate, and severe hepatic steatosis was 0.900, 0.745, and 0.603, respectively. NLV (50 mm) values and NLV-SD (50 mm) values between two readers showed excellent repeatability and the intraclass correlation coefficient (ICC) was 0.930 (p < 0.001) and 0.899 (p < 0.001). Hepatic steatosis was the only determinant factor for NLV value and NLV-SD value (p = 0.012, p = 0.038). CONCLUSION: The NLV (50 mm) and NLV-SD (50 mm) provided good diagnostic performance in detecting the varying degrees of hepatic steatosis with great reproducibility. This study showed that the degree of steatosis was the only significant factor affecting the NLV value and NLV-SD value.
format Online
Article
Text
id pubmed-8807465
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-88074652022-02-14 Quantitative evaluation of hepatic steatosis using novel ultrasound technology normalized local variance (NLV) and its standard deviation with different ROIs in patients with metabolic-associated fatty liver disease: a pilot study Zhao, Yanan Zhang, Chao Xu, Shaoyan Zhang, Hui Wei, Shumei Huang, Pengfei Zhang, Lufei Wong, Yik Ning Xu, Wen Huang, Pintong Abdom Radiol (NY) Special Section: Diffuse Liver Disease PURPOSE: The purpose of this study was to evaluate the diagnostic performance of novel ultrasound technology normalized local variance (NLV) and the standard deviation of NLV (NLV-SD) using different ROIs for hepatic steatosis in patients with metabolic-associated fatty liver disease (MAFLD) and to identify the factors that influence the NLV value and NLV-SD value, using pathology results as the gold standard. METHODS: We prospectively enrolled 34 consecutive patients with suspected MAFLD who underwent percutaneous liver biopsy for evaluation of hepatic steatosis from June 2020 to December 2020. All patients underwent ultrasound and NLV examinations. NLV values and NLV-SD values were measured using different ROIs just before the liver biopsy procedure. RESULTS: The distribution of hepatic steatosis grade on histopathology was 4/19/6/5 for none (< 5%)/ mild (5–33%)/ moderate (> 33–66%)/ and severe steatosis (> 66%), respectively. The NLV value with 50-mm-diameter ROI and NLV-SD value with 50-mm-diameter ROI showed a significant negative correlation with hepatic steatosis (spearman correlation coefficient: − 0.449, p = 0.008; − 0.471, p = 0.005). The AUROC of NLV (50 mm) for the detection of mild, moderate, and severe hepatic steatosis was 0.875, 0.735, and 0.583, respectively. The AUROC of NLV-SD (50 mm) for the detection of mild, moderate, and severe hepatic steatosis was 0.900, 0.745, and 0.603, respectively. NLV (50 mm) values and NLV-SD (50 mm) values between two readers showed excellent repeatability and the intraclass correlation coefficient (ICC) was 0.930 (p < 0.001) and 0.899 (p < 0.001). Hepatic steatosis was the only determinant factor for NLV value and NLV-SD value (p = 0.012, p = 0.038). CONCLUSION: The NLV (50 mm) and NLV-SD (50 mm) provided good diagnostic performance in detecting the varying degrees of hepatic steatosis with great reproducibility. This study showed that the degree of steatosis was the only significant factor affecting the NLV value and NLV-SD value. Springer US 2021-12-27 2022 /pmc/articles/PMC8807465/ /pubmed/34958409 http://dx.doi.org/10.1007/s00261-021-03394-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Special Section: Diffuse Liver Disease
Zhao, Yanan
Zhang, Chao
Xu, Shaoyan
Zhang, Hui
Wei, Shumei
Huang, Pengfei
Zhang, Lufei
Wong, Yik Ning
Xu, Wen
Huang, Pintong
Quantitative evaluation of hepatic steatosis using novel ultrasound technology normalized local variance (NLV) and its standard deviation with different ROIs in patients with metabolic-associated fatty liver disease: a pilot study
title Quantitative evaluation of hepatic steatosis using novel ultrasound technology normalized local variance (NLV) and its standard deviation with different ROIs in patients with metabolic-associated fatty liver disease: a pilot study
title_full Quantitative evaluation of hepatic steatosis using novel ultrasound technology normalized local variance (NLV) and its standard deviation with different ROIs in patients with metabolic-associated fatty liver disease: a pilot study
title_fullStr Quantitative evaluation of hepatic steatosis using novel ultrasound technology normalized local variance (NLV) and its standard deviation with different ROIs in patients with metabolic-associated fatty liver disease: a pilot study
title_full_unstemmed Quantitative evaluation of hepatic steatosis using novel ultrasound technology normalized local variance (NLV) and its standard deviation with different ROIs in patients with metabolic-associated fatty liver disease: a pilot study
title_short Quantitative evaluation of hepatic steatosis using novel ultrasound technology normalized local variance (NLV) and its standard deviation with different ROIs in patients with metabolic-associated fatty liver disease: a pilot study
title_sort quantitative evaluation of hepatic steatosis using novel ultrasound technology normalized local variance (nlv) and its standard deviation with different rois in patients with metabolic-associated fatty liver disease: a pilot study
topic Special Section: Diffuse Liver Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807465/
https://www.ncbi.nlm.nih.gov/pubmed/34958409
http://dx.doi.org/10.1007/s00261-021-03394-0
work_keys_str_mv AT zhaoyanan quantitativeevaluationofhepaticsteatosisusingnovelultrasoundtechnologynormalizedlocalvariancenlvanditsstandarddeviationwithdifferentroisinpatientswithmetabolicassociatedfattyliverdiseaseapilotstudy
AT zhangchao quantitativeevaluationofhepaticsteatosisusingnovelultrasoundtechnologynormalizedlocalvariancenlvanditsstandarddeviationwithdifferentroisinpatientswithmetabolicassociatedfattyliverdiseaseapilotstudy
AT xushaoyan quantitativeevaluationofhepaticsteatosisusingnovelultrasoundtechnologynormalizedlocalvariancenlvanditsstandarddeviationwithdifferentroisinpatientswithmetabolicassociatedfattyliverdiseaseapilotstudy
AT zhanghui quantitativeevaluationofhepaticsteatosisusingnovelultrasoundtechnologynormalizedlocalvariancenlvanditsstandarddeviationwithdifferentroisinpatientswithmetabolicassociatedfattyliverdiseaseapilotstudy
AT weishumei quantitativeevaluationofhepaticsteatosisusingnovelultrasoundtechnologynormalizedlocalvariancenlvanditsstandarddeviationwithdifferentroisinpatientswithmetabolicassociatedfattyliverdiseaseapilotstudy
AT huangpengfei quantitativeevaluationofhepaticsteatosisusingnovelultrasoundtechnologynormalizedlocalvariancenlvanditsstandarddeviationwithdifferentroisinpatientswithmetabolicassociatedfattyliverdiseaseapilotstudy
AT zhanglufei quantitativeevaluationofhepaticsteatosisusingnovelultrasoundtechnologynormalizedlocalvariancenlvanditsstandarddeviationwithdifferentroisinpatientswithmetabolicassociatedfattyliverdiseaseapilotstudy
AT wongyikning quantitativeevaluationofhepaticsteatosisusingnovelultrasoundtechnologynormalizedlocalvariancenlvanditsstandarddeviationwithdifferentroisinpatientswithmetabolicassociatedfattyliverdiseaseapilotstudy
AT xuwen quantitativeevaluationofhepaticsteatosisusingnovelultrasoundtechnologynormalizedlocalvariancenlvanditsstandarddeviationwithdifferentroisinpatientswithmetabolicassociatedfattyliverdiseaseapilotstudy
AT huangpintong quantitativeevaluationofhepaticsteatosisusingnovelultrasoundtechnologynormalizedlocalvariancenlvanditsstandarddeviationwithdifferentroisinpatientswithmetabolicassociatedfattyliverdiseaseapilotstudy